Of the total 302 patients treated with the Lilly drug, five or 1.7%, had to be hospitalized or required an emergency room visit. That compared with 6% in the placebo group, Lilly said.
Lilly says antibody drug cuts COVID-19 hospitalization, may seek emergency use nod
